Clinical Trials
3 trialsNCT05250336 2022-02-22
Tumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast Cancer
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Unknown
NCT02560311 2015-09-25
Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis
University of Zurich
Unknown
NCT00189631 2005-12-08
UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to Chemotherapy
Association Européenne de Recherche en Oncologie
Phase 3 Unknown